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Summary. Bronchiolitis is the leading cause of hospitalization in infants under 12 months. Our
aims were to analyze epidemiological characteristics of infants with bronchiolitis over 10
consecutive seasons and to evaluate whether there are any clinical differences between infants
hospitalized for bronchiolitis during epidemic peak months and infants in non-peak months. We
enrolled consecutive enrolled 723 previously healthy term infants hospitalized at the Paediatric
Emergency Department, “Sapienza” University of Rome over the period 2004–2014. Fourteen
respiratory viruses were detected from nasopharyngeal aspirates by molecular methods.
Clinical and demographic data were extracted from clinical charts. Viruses were detected in
351 infants (48.5%): RSV in 234 (32.4%), RV in 44 (6.1%), hBoV in 11 (1.5%), hMPV in 12
(1.6%), co-infections in 39 (5.4%), and other viruses in 11 (1.5%). Analyzing the 10 epidemic
seasons, we found higher incidence for bronchiolitis every 4 years with a peak during the
months December–January. Infants hospitalized during peak months had lower family history
for asthma (P¼0.003), more smoking mothers during pregnancy (P¼0.036), were slightly
higher breastfed (0.056), had lower number of blood eosinophils (P¼0.015) and had a higher
clinical severity score (P¼0.017). RSV was detected mostly during peak months, while RV was
equally distributed during the seasons. We found some variations in bronchiolitis incidence
during epidemics, and discriminative characteristics in infants hospitalized for bronchiolitis
during peak months and in non-peak months, that might reflect two different populations of
children. Pediatr Pulmonol. 2016; 9999:XX–XX.  2016 Wiley Periodicals, Inc.
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INTRODUCTION
Acute bronchiolitis is the most common lower
respiratory tract infection in infants and the leading
cause of hospitalization in this group of patients.1
Bronchiolitis is diagnosed mostly in winter, in
particular between October and May during respiratory
viruses circulation periods. It is well known that the
number of infants with bronchiolitis rapidly increases
from the beginning of the epidemic, it reaches a peak with
a plateau during the 2–3 central months and then rapidly
decreases during the last months. The identification of a
virus is higher during the peakmonths of the epidemic and
it is lower at the beginning and at the end, but it is not clear
whether patients who have bronchiolitis during the peak
months have different demographic and clinical charac-
teristics, comparing to those who have bronchiolitis
during the non-peak months.1,2 Furthermore, it has been
shown that also the number of patients with bronchiolitis
may change from 1 year to the other probably due to
viruses’ characteristics and the immunological status of
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the patients.3 Because of the conflict that exists in the
definition, a more homogenous material, following strict
inclusion criteria are needed.
The evident relationship between respiratory syncytial
virus (RSV) and bronchiolitis has been widely described
in the last decades.4 Recently, with the improvement in
viral identification techniques, it has been showed that
also other respiratory viruses are associated with this
disease, but the clinical characteristics of infants with
bronchiolitis from other respiratory viruses is still
controversial.5–8
The main purpose of our study was to describe the
prevalence and the epidemiology of 14 respiratory viruses
in previously healthy full term infants hospitalized for
bronchiolitis during 10 consecutive annual epidemic
periods. In addition we tested the hypothesis that infants
hospitalized during the peak months of bronchiolitis
epidemics were different from those hospitalized during
the non-peak months, by comparing demographic and
clinical characteristics in those two groups of infants.
MATERIALS AND METHODS
Patients
We prospectively enrolled 723 consecutive infants
(median age 2.13 months, range [0.23–11.97], 395
[54.6%] male) hospitalized for bronchiolitis in the
Paediatric Emergency Department of “Sapienza” Univer-
sity of Rome during 10 consecutive annual epidemic
periods from October to May, from the years 2004 to
2014.
Acute bronchiolitis was clinically defined as the first
episode of acute lower respiratory tract infection in
infants less than 12 months, characterized by the acute
onset of cough, tachypnoea, retraction, and diffuse
crackles on chest auscultation.9 Exclusion criteria were
prematurity and underlying chronic diseases, such as
cystic fibrosis, interstitial lung disease, congenital heart
disease, and immunodeficiency.
Detailed demographic characteristics were obtained
from parents with a structured questionnaire; clinical and
laboratory data were extracted from patients’ medical
files. Studied variables included age, gender, breast
feeding history, family smoking habit, school attendance
by siblings, family history for asthma and atopy, blood
eosinophil count, chest radiological findings, and number
of days of hospitalization. In addition, a clinical severity
score ranging from 0 to 8 was assigned to each infant on
admission in the hospital according to respiratory rate,
arterial oxygen saturation on room air, presence of
retractions, and ability to tolerate oral feeding.10
Considering the high prevalence of bronchiolitis during
specific months of the years, we divided our patients in
infants whowere hospitalized during the peakmonths and
infants who were hospitalized during the non-peak
months. For peak months, we empirically considered
the 3 central months of each epidemic season (including
at least 75% of the population/year).
The parents of all infants were asked to participate in
the study and gave informed consents. The study was
approved by the research and ethics committee of the
Hospital.
Virus Detection
To detect respiratory viruses, we collected nasopha-
ryngeal aspirates within the first day of hospitalization
using 3ml of sterile isotonic solution injected into each
nostril and aspirated back with a syringe. We sent the
samples on ice to the virology laboratory to analyze:
200ml of respiratory specimens were used to extract
nucleic acid with the total nucleic acid isolation kit
(Roche Diagnostics, Mannheim, Germany), eluting with
50ml of the supplied elution buffer. A panel of either
reverse transcriptase (RT) or nested PCR assays has been
used to detect 14 respiratory viruses: RSV, Rhinoviruses
(RV), influenza virus (IV) A and B, human Coronavirus
(hCoV) OC43, 229E, NL-63 and HUK1, Adenovirus, RV,
Parainfluenza virus (PIV) 1–3, and Human Metapneu-
movirus (hMPV).11 Human Bocavirus (hBoV) was
detected with a different PCR method used by Allander
et al.12 Rhinoviruses were detected targeting the 50 UTR
region, well conserved among Rhinoviruses and respira-
tory Enteroviruses so that they are not distinguished by
this test. A subset of RV-positive samples was amplified
and sequenced in less conserved regions (VP4-VP2) and 1
out of 38 resulted to be Enterovirus 68.
Statistical Analysis
For statistical reasons, we decide to consider occa-
sional viruses all the viruses found with incidence lower
than 1% in the 10 years. Continuous variables values were
expressed as mean SD or median and range and
categorical variables as number and percentages. A
one-way analysis of variance (ANOVA) and Student’s
t-test were used for the comparison of continues variables.
The Mann–Whitney and Kruskal–Wallis tests were used
to analyze categorical independent variables. We consid-
ered statistically significant a P< 0.05. Statistical analy-
sis was performed using the SPSS Software (version 21.0;
SPSS Inc., Chicago, IL).
RESULTS
Only 6.5% of parents approached declined to take part
to the study. Among the 723 previously healthy, term,
infants consecutively hospitalized for bronchiolitis, we
were able to identified 391 viruses from the nasopharyn-
geal aspirates of 351 children. RSV was identified in 234
infants, RV in 44, hBoV in 11, hMPV in 12, PIV in 5 (four
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PIV 3 and one PIV 1), hCoV in 2, IV in 4; coinfections
were identified in 39 infants (RSV-RV n¼ 13, RSV-hBoV
n¼ 13, RSV-Influenza n¼ 2, RSV-hMPV n¼ 2, RSV-
PIV 3 n¼ 1, hBoV-hMPV n¼ 1, hBoV-PIV 1 n¼ 1,
RV-hMPV n¼ 4, RV-PIV 3 n¼ 1, RSV-RV-hMPV n¼ 1).
Comparing clinical characteristics of bronchiolitis
from different viruses, we found that RSV patients
were significantly younger (vs. hBoV P< 0.001) and had
a higher severity score with respect to other groups
(P< 0.041). A higher number of blood eosinophils was
found in RV patients than in other groups (P< 0.014). No
differences were found in terms of length of hospitaliza-
tion, demographic data, and clinical severity score
between different viruses’ groups, including coinfected
infants.
Considering the 10 epidemics, we observed a signifi-
cantly higher number of infants hospitalized with
bronchiolitis in the 3rd (n¼ 102) and 7th (n¼ 105)
epidemics (2006–2007 and 2010–2011) than in the 4th
(n¼ 47) and 8th (n¼ 73) epidemics (2007–2008 and
2011–2012) (P< 0.001) (Fig. 1a).
Most of the patients were recruited in the winter
months, especially in December–February and, analyzing
viruses’ detection, we found that RSV follows the
temporal trend of the disease, while other viruses were
equally distributed over the year (Fig. 1b). Comparing the
epidemiology over the 10 years, a variability of the month
with the higher incidence, even within the winter months,
was found. Particularly, the month with a higher number
of hospitalization for bronchiolitis was January in seven
epidemics (3rd–5th, 7th–10th) and February in three (1st,
2nd, and 6th) (Fig. 2).
Dividing infants according to the hospitalization during
the peak months or non-peak months, we found some
statistically significant differences in terms of risk factors
for respiratory diseases. The 596 infants hospitalized in
the peak months had less frequently both parents with
asthma (P¼ 0.003), had higher maternal smoke during
pregnancy (P¼ 0.036) and were slightly higher breastfed
(P¼ 0.056). Moreover, children in the peak months had
lower number of eosinophils (P¼ 0.015) and had a higher
severity score (P¼ 0.017) than infants in non-peak
months.
Analyzing viruses’ detection, RSV was more fre-
quently detected in peak months than non-peak months,
differing fromRV (P¼ 0.029). No differences were found
for other clinical variables evaluated (Table 1).
DISCUSSION
With the present study, we examined the epidemiology
and the characteristics of acute bronchiolitis, in infants
hospitalized in a single Italian pediatric medical center,
over 10 consecutive epidemic seasons. The peak of
hospitalization for bronchiolitis tended to come early to
January and showed an increase of cases every 4 years.
RSV was confirmed as the most common agent of
bronchiolitis, followed by RV, hBoV, and hMPV;
coinfections have been detected in 5.4% of children. In
our study, we confirmed that RSV infection was present in
younger and more clinically severe infants, while infants
with RV had higher number of blood eosinophils. Finally,
differences in terms of demographic and clinical
characteristics have been found between infants hospital-
ized for bronchiolitis during the peak months and ones
during non-peak months.
One strength of our study is that we included
only infants with a well-characterized definition of
Fig. 1. (a) Number of infants hospitalized for bronchiolitis over 10 epidemics. (b) Number of
infants hospitalized for bronchiolitis by infection type (RSV, RV, hBoV, hMPV, and coinfections)
during the 10 epidemics divided by month.
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bronchiolitis (infants younger than 12 months presenting
with their first episode of lower respiratory infection, who
had diffuse crackles on auscultation). Otherwise, the
American Pediatric Academy defines bronchiolitis as the
first episode of acute viral wheeze occurring in infants
less than 2 years.1 In order to exclude infants with virus
associated episodes of wheezing, having wheezing alone
was not considered sufficient for inclusion in the study.10
Comparing hospitalization for bronchiolitis during
different years, we found a peak of incidence in the 3rd
and 7th seasons in respect to the subsequent year
indicating that respiratory virus circulation apparently
Fig. 2. Distribution of identified viruses in infants hospitalized for bronchiolitis over the 10
epidemics without (a) and with (b) negative infants.
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increase every 4 years. Alternating circulation of RSV
types A and B could explain different rates of hospitali-
zation in different epidemic seasons, but unfortunately, as
stated below as a study limitation, we did not test for
viruses’ subtypes along the whole study period. Moore
et al. studied duration of immunity after RSV infection
assuming the need of a sufficient number of infected
people at the same time to gain population immunity also
considering that immunity could wane several months
before the onset of a subsequent RSV season. Differences
in viral circulation during the years could be linked to the
circulation of different viral genotypes or, than, to the
“herd immunity.”8,13 In fact, the spread of a new RSVA
subtype (ON1) has been recently demonstrated in
Rome.14
Our finding of an anticipation of the month with the
higher incidence of bronchiolitis (December or January
instead of March) could be linked to changes in climatic
conditions, such as temperature or humidity, and to air
pollution modification over different years.15 This fact
could influence viral spread along with predisposition of
patients to respiratory infection.
Comparing bronchiolitis from different viruses in 10
consecutive seasons, we confirmed RSV as more severe
agent affecting younger infants. Moreover, while RV was
equally distributed during the year, most of RSV was
detected during winter months, strongly correlating with
bronchiolitis incidence trend, as other studies have
already shown.16 We think that this fact may be caused
by climate factors, such as temperature, air pressure, and
pollution modifications could modulate even the season-
ality of viruses, as other studies already evidenced.17,18 In
fact, the study by Hervas et al. concluded that the mean
temperature and atmospheric pressure were the main
factors for RSV activity.18
Observing the distribution of bronchiolitis during the
year, we were able to isolate peak and non-peak months
of hospitalization for this disease with some differences
between the two populations. An association between
peak bronchiolitis, incidence, and clinical severity was
found. It could be linked to our finding of higher
incidence of RSV in peak months with respect to the
non-peak months. Having both parents with asthma and
the number of eosinophils were significantly lower
during peak months. These facts may justify the
different characteristics of this population hospitalized
in a period with lower viruses detection and less severe
viral infections. On the other hand, analyzing risk
factors for respiratory diseases, infants exposed to
maternal smoke during pregnancy were hospitalized
more during peak months; this could be linked to
modification of respiratory mucosa and subsequent
predisposition to viral infection, in particular from RSV
in at risk infants. Noakes et al. studied that smoke
increases early susceptibility to infection and, then, the
subsequent IgA responses.19–23
Our study has some limitations. First, as we discussed
in our previous article,10 although the sensitive and
comprehensive PCR method, our virus detection rate was
poor. It could be partly due to technical problems related
to collecting and storing samples. Otherwise, some of the
virus negative cases may be related to undetected
pathogens. Finally, we did not test for viruses subtypes.
In conclusion, we found some variations in bronchioli-
tis incidence during epidemics, and discriminative
characteristics in infants hospitalized for bronchiolitis
during peak months and in non-peak months that might
reflect two different populations of children.
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Sex (male) 54% 57.5% ns
Age (days) 77.45 58.49 83.34 56.14 ns
Gestational age (weeks) 38.81 1.26 38.84 1.10 ns
Family history of asthma 21.3% 25.2% ns
Both parents with positive
history of asthma
0.3% 3.8% 0.003
Family history of atopy 34.4% 33.9% ns




Caesarian section 51.8% 46.8% ns
Breastfeeding at recovery 78% 70.1% 0.056
Chest x-ray consolidation 55.2% 55.8% ns
WBC 11,589 4,657 11,821 5,591 ns
Blood eosinophils1 80 (0–1,412) 120 (0–1,315) 0.015
C-reactive protein (mg/dl) 0.44 (0–16.98) 0.3 (0–7.18) ns
Severity score:
Time 0 3.31 2.08 2.79 1.98 0.017
Time 24 hr 2.28 1.83 1.55 1.56 0.001
Time 48 hr 1.59 1.61 0.96 1.12 0.001
Days of hospitalization 5.13 2.44 4.75 1.79 ns
Negative for viruses 300 (50.3%) 72 (56.7%) ns
RSV only 204 (34.2%) 30 (23.6%) 0.022
RV only 32 (5.4%) 12 (9.4%) 0.067
Bocavirus 11 (1.8%) 0 ns
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